Report finds China targeted AstraZeneca in fraud probe over cancer treatment

Report finds China targeted AstraZeneca in fraud probe over cancer treatment

Pharmaceutical giant AstraZeneca, whose China president is under investigation, was previously investigated for medical insurance fraud cases involving cancer medication sales, according to new Chinese media reports. The news comes after the British-Swedish company announced on its official website last week that its China chief Leon Wang was cooperating “with an ongoing investigation”, and its … Read more

China investigation of drug firm exec deals latest blow to foreign business confidence

China investigation of drug firm exec deals latest blow to foreign business confidence

An investigation of a top China executive from British-Swedish company AstraZeneca – and the lack of transparency surrounding the case – is set to deal another blow to foreign business confidence in the country, according to observers. AstraZeneca, the largest foreign pharmaceutical company in China, said on Wednesday that its China president, Leon Wang, was … Read more

Covishield Side Effects: Covishield side effects: Doctors’ group urges govt to review all Covid vaccines

Covishield Side Effects: Covishield side effects: Doctors’ group urges govt to review all Covid vaccines

NEW DELHI: In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under … Read more

AstraZeneca withdraws Covid-19 vaccine citing low demand

AstraZeneca withdraws Covid-19 vaccine citing low demand

AstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a plethora of new shots that has led to a decline in demand. A healthcare worker prepares doses of the AstraZeneca Covid-19 vaccine at a vaccine hub in the Auditorium della Tecnica in Rome in June 2021. AstraZeneca is withdrawing its highly successful … Read more

AstraZeneca rises as key lung cancer drug scores another win

AstraZeneca rises as key lung cancer drug scores another win

AstraZeneca Plc shares rose after trial data showed Tagrisso slowed disease progression in patients with advanced lung cancer in another win for the pharmaceutial giant’s blockbuster drug.The trial looked at Tagrisso as a maintenance therapy for patients with non-small cell lung cancer and a specific genetic mutation, where there is no targeted treatment available.AstraZeneca said … Read more

National pharmacare plan is in limbo as health minister calls pending deadline ‘arbitrary’

National pharmacare plan is in limbo as health minister calls pending deadline ‘arbitrary’

Health Minister Mark Holland signalled Tuesday the government is unlikely to meet the end-of-the-year deadline imposed by the NDP for passing pharmacare legislation — a condition of the supply-and-confidence agreement that was struck to keep the Liberals in power until 2025. Holland said talks are ongoing with NDP MP Don Davies, the party’s health critic, … Read more